Skip to content

HIV and schistosomiasis programmes should be combined to reduce the spread of HIV

Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?

Do integrase inhibitors raise the risk of obesity?

Potential drug interactions among people with HIV taking statins

Growth in positive attitudes towards PrEP among Australian gay and bisexual men

Six innovative models for PrEP services

South Africa reports successful third-line HIV treatment programme

Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia